INDIANAPOLIS (dpa-AFX) - Der Pharmakonzern Eli Lilly and Company wächst weiter rasant. Auch im vergangenen…
…
…
INDIANAPOLIS (dpa-AFX) - Der Pharmakonzern Lilly wächst weiter rasant. Auch im vergangenen Quartal konnte sich…
Here are Thursdays biggest calls on Wall Street.…
Eli Lilly reported revenue and adjusted earnings that topped expectations, lifted by $1.4 billion in sales from its blockbuster diabetes…
Eli Lillys Mounjaro, a diabetes drug that is expected to received FDA approval for weight loss treatment, generated more than…
Eli Lilly beats quarterly revenue estimates on Mounjaro strength…
Eli Lilly falls after cutting full-year profit forecast…
Eli Lilly (LLY) beats third-quarter estimates for earnings as well as sales. It cut its earnings guidance for 2023 on…
Apple earnings, Eli Lilly, ConocoPhillips: 3 things to watch…
Eli Lilly now owns the opt-in rights to three more of Verves cardiovascular drugs.…
Shares in Beam Therapeutics Inc were up 10% premarket following a deal to sell rights to a licensing deal with Verve Therapeutics…
…
…
The earnings season also continues with Apple, Airbnb, McDonalds, Moderna and Eli Lilly.…
Companies — both big and small — are hoping to grab a piece of the lucrative anti-obesity drug market. Piper…
Eli Lilly and Co (NYSE:LLY) is scheduled to report earnings before the market opens on Thursday, with analysts expecting revenue…
Eli Lilly and Co (NYSE:LLY) has announced that its Omvoh drug has been approved by the US Food and Drug…
Merck (MRK), Sanofi (SNY) and Novartis (NVS) report third-quarter results. FDA approves Pfizers (PFE) Penbraya and Eli Lillys (LLY) Omvoh…
On Eli Lillys (LLY) third-quarter conference call, investor focus is likely to be on the sales of its new diabetes…
…
Hundreds of online sellers are offering Eli Lilly’ & Co.’s LLY retatrutide weight-loss drug for sale, even though the drug…
…
…
The effort comes after Sanofi, Eli Lilly and Novo Nordisk announced sweeping insulin price cuts earlier this year.…
Eli Lilly and Novo Nordisk are both battling demand issues for flagship treatments.…
…
…
This month has been more kind to stocks than last. Our top performers at the halfway mark include Foot Locker…
Whats good for Novo Nordisks Ozempic is also good for Eli Lillys Mounjaro.…
Whats good for Novo Nordisks Ozempic is also good for Eli Lillys Mounjaro.…
Two experts see major challenges facing the adoption of Novo Nordisk and Eli Lillys obesity drugs.…
Eli Lillys (LLY) mirikizumab meets the main goals in a Crohns disease study. PFE, MRK and JNJ provide updates on…
Based on this data, Eli Lilly (LLY) will initiate regulatory submissions worldwide next year seeking regulatory approval for mirikizumab in…
Eli Lillys (LLY) Mounjaro is also being evaluated in clinical studies for patients who are obese or overweight and have…
…
Bristol Myers Squibb, Mirati Therapeutics, Eli Lilly, POINT Biopharma and Pfizer are part of the Zacks top Analyst Blog.…
Broadcom (AVGO) and Eli Lilly (LLY) are among the 15 Club stocks with a streak of annual dividend growth that…
…
…
ROCKVILLE, Md., Oct. 06, 2023 (GLOBE NEWSWIRE) -- The American Kidney Fund (AKF) today announced that Boehringer Ingelheim…
Here are Fridays biggest calls on Wall Street.…
Eli Lilly (LLY) is wisely broadening out its drug pipeline through a series of acquisitions of smaller companies.…
…
…
Eli Lilly: Diabetes & Obesity president to retire; shares dip…
Eli Lilly and Co said on Wednesday that the head of its diabetes and obesity division, Mike Mason, will retire…
Eli Lillys head of diabetes and obesity unit to retire…
American pharmaceutical company Eli Lilly plans to acquire cancer therapy firm Point Biopharma Global, the companies announced Tuesday, an expansion…